Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2008
11/20/2008WO2008138732A1 Oxime ester photoinitiators
11/20/2008WO2008138724A1 Oxime ester photoinitiators
11/20/2008WO2008094912B1 Substituted gamma lactams as therapeutic agents
11/20/2008WO2008081476A3 Process for preparing duloxetine hydrochloride
11/20/2008WO2007110418A3 Substituted 5-hetaryl-4-aminopyrimidines
11/20/2008US20080287687 Production method of diphenylalanine-Ni (II) complex
11/20/2008US20080287504 Such as N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; Cannabinoid-1 (CB1) receptor; dietetics
11/20/2008US20080287498 Optically active isomers of ketotifen and therapeutically active metabolites thereof
11/20/2008US20080287473 Novel molecules for regulating cell death
11/20/2008US20080287454 Cxcr4 antagonists
11/20/2008US20080287449 Aza-tripeptide hepatitis c serine protease inhibitors
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080286810 Use of Inhibtors of Glutaminyl Cyclases for Treatment and Prevention of Disease
11/20/2008CA2687303A1 ((phenyl)imidazolyl)methylheteroaryl compounds
11/20/2008CA2685888A1 Substituted heterocyclic derivatives and their pharmaceutical use and compositions
11/19/2008EP1992624A1 Heteroarylamide pyrimidone compounds
11/19/2008EP1992621A1 Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
11/19/2008EP1991540A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors
11/19/2008EP1991532A2 Compositions and methods for inhibition of the jak pathway
11/19/2008EP1991530A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors
11/19/2008EP1991528A2 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
11/19/2008EP1991233A2 Hydroxypiperidine derivatives and uses thereof
11/19/2008EP1991226A2 Inhibitors of histone deacetylase
11/19/2008CN101309919A Novel pyrrolidine derivatives as inhibitors of coagulation factor XA
11/19/2008CN101309918A [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases
11/19/2008CN101309908A Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
11/19/2008CN100435027C Organic light receptor with charge transfer compound for electronic photographing
11/18/2008US7453002 Five-membered heterocycles useful as serine protease inhibitors
11/18/2008US7452997 Tetrahydro-indazole cannabinoid modulators
11/18/2008US7452995 Aryl aniline β2 adrenergic receptor agonists
11/18/2008US7452914 Spiro-benzo[c]chromene derivatives useful as modulators of the estrogen receptors
11/18/2008US7452882 Thyroid hormone analogs
11/18/2008US7452881 Such as N-[3-(2-diethylaminoethyl)-1H-indol-5-yl]-5-chloro-3-methylbenzo[b]thiophene-2-sulphonamide; serotonin receptors antagonist; anxiolytic, antidepressant, cognitive activator, senile dementia, psychosis, attention deficit/hyperactivity disorder
11/18/2008US7452874 Thrombopoietin mimetics
11/18/2008US7452873 Inhibitors of GSK-3 and uses thereof
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2383630C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
11/18/2008CA2383222C Optically active isomers of ketotifen and therapeutically active metabolites thereof
11/18/2008CA2340912C Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof
11/18/2008CA2320822C Substituted isoindolones and their use as cyclic gmp modulators in medicaments
11/18/2008CA2318184C Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative as selective endothelin antagonists
11/18/2008CA2230516C Pyrimidine derivatives
11/13/2008WO2008137809A2 [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl] -5-chloro-thiophen-2-yl-sulfonylurea salts, in different crystalline forms, pharmaceutical compositions thereof
11/13/2008WO2008135824A1 Oxyalkylpyrazole compounds useful in therapy
11/13/2008WO2008135592A1 Oligothiophene derivatives
11/13/2008WO2008114023A3 Phthalazinone derivatives
11/13/2008US20080280952 Pyridine Derivatives as Connabinoid Receptor Modulators
11/13/2008US20080280924 Pyridine and pyrimidine derivatives as mglur2 antagonists
11/13/2008US20080280919 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
11/13/2008US20080280918 phosphodiesterase enzyme inhibitor; 4-[(3-chlorophenyl)amino]-2-ethyl-5-(1-hydroxyethyl)-6-phenylpyridazin-3(2H)-one; potent antiinflammatory agent; asthma, atopic dermatitis, psoriasis, chronic obstructive pulmonary disease, rheumatoid arthritis, irritable bowel disease
11/13/2008US20080280905 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
11/13/2008US20080280895 5-Amino-4-Hydroxy-7-(1H-Indolmethyl)-8-Methylnonamide Derivatives as Renin Inhibitors for the Treatment of Hypertension
11/13/2008US20080280873 Biaryl Substituted Pyrazinones as Sodium Channel Blockers
11/13/2008US20080280868 Pyridine Derivatives and Their Use as Cb2 Receptor Modulators
11/13/2008CA2686221A1 [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto
11/13/2008CA2685389A1 Tricyclic compounds as matrix metalloproteinase inhibitors
11/13/2008CA2680803A1 Derivatives of the aminated hydroxyquinoline class for treating cancers
11/12/2008EP1990340A1 Oligothiophene derivatives
11/12/2008EP1990335A1 17 beta hsd type 5 inhibitor
11/12/2008EP1989200A2 [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases
11/12/2008EP1989185A1 Therapeutic compounds
11/12/2008EP1989184A2 Insecticidal n-substituted (6-haloalkylpyridin-3-yl)alkyl sulfoximines
11/12/2008EP1893597B1 Ampa receptor potentiators
11/12/2008EP1751138B9 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
11/12/2008EP1727808B1 Biaryl amino acids and their use in dna binding oligomers
11/12/2008EP1703905B1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors
11/12/2008EP1343503B1 Heteroaryl urea neuropeptide y y5 receptor antagonists
11/12/2008CN101304992A 1, 3-disubstituted indole derivatives for use as PPAR modulators
11/12/2008CN101304989A Carbocyclic fused cyclic amines as inhibitors of the coagulation factor XA
11/12/2008CN101304986A Regioselective process for preparing benzimidazole thiophenes
11/12/2008CN101304981A P2x7 receptor antagonists and methods of use
11/12/2008CN101302194A Synthetic method of polysubstituted chinoline compound
11/12/2008CN101302184A Indoline sulfanilamide compound
11/12/2008CN101302182A Virus polymerase inhibitors
11/12/2008CN101302180A 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
11/12/2008CN100432070C Novel sulfamides and their use as endothelin receptor antagonists
11/11/2008US7449576 potent antagonists of the CCR1 receptor; inflammation; (5-Chloro-2-piperazin-1-yl-phenyl)-phenyl-methanone
11/11/2008US7449575 preparing 4-[[4-amino-6-[(2,6-dichlorophenyl)methyl]-1,3,5-triazin-2-yl]amino]benzonitrile by reacting 2,6-dichlorobenzeneethanimidamide with phenyl N'-cyano-N-(4-cyanophenyl)-carbamimidate in a reaction-inert solvent; HIV (Human Immunodeficiency Virus) infection
11/11/2008US7449484 angiogenesis inhibitor; Tie2 receptor kinase inhibitors; 2-tert-Butyl-4-naphthalen-2-yl-5-pyridin-4-yl-imidazole;2-tert-Butyl-4-(6-Ethoxynaphthalen-2-yl)-5-pyridin-4-yl-imidazole;4-(2-tert-Butyl-5-(6-methoxy-naphthalen-2-yl)-3H-imidazol-4-yl)-pyridine; etc.
11/11/2008US7449483 e.g. 2-(Ethyl-{4-[2-methyl-3-(4-trifluoromethyl-phenyl)-benzo[b]thiophen-6-yl]-butyl}-amino)-ethanol; 2,3-oxidosqualene-lanosterol cyclase inhibitor; antidiabetic, antitumor, antiproliferative agent; hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones
11/11/2008US7449481 Thio-substituted biaryl-methanesulfinyl derivatives
11/11/2008US7449480 Small molecule inhibitors of HER2 expression
11/11/2008US7449474 Tri-substituted ureas as cytokine inhibitors
11/11/2008US7449465 glycogen synthase kinase 3 alpha and 3 beta inhibitors; improved phanrmacological activity, potency, selectivity, solubility, permeability, metabolic stability; bipolar disorder; Alzheimer's disease; type II diabetes, neuropathic pain; depression; inflammatory diseases
11/11/2008US7449464 4-{3-[4-(6-Chlorobenzothiazol-2-yl)-1,4-diazepan-1-ylcarbonyl]benzyl}-1(2H)-phthalazinone; Cancer, BRCA deficient
11/11/2008US7449456 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
11/06/2008WO2008133955A1 6-phenylpyrimidinones as pim modulators
11/06/2008WO2008133900A1 Quaternary ammonium compounds useful as muscarinic receptor antagonists
11/06/2008WO2008133896A2 Dual-acting antihypertensive agents
11/06/2008WO2008133288A1 Tricyclic aryl compounds
11/06/2008WO2008132679A1 Bridged six-membered ring compounds
11/06/2008WO2008132162A1 3- (sulphonylamino) -phenyl-2 -hydroxy-ethylamino derivatives useful as beta-agonists, processes for preparing them and their use as medicaments
11/06/2008WO2008131972A1 Arylmethylen substituted n-acyl-gamma-aminoalcohols
11/06/2008WO2008100456A3 Functionally selective alpha2c adrenoreceptor agonists
11/06/2008WO2008073933A3 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
11/06/2008WO2008020306A3 Isoindole derivatives
11/06/2008US20080275233 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
11/06/2008US20080275105 Thienyl-acylhydrazone derivatives; muscular disorders; antiischemic, hypotensive, and antispasmodic agents; cardiovascular and respiratory system disorders
11/06/2008US20080275090 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
11/06/2008US20080275066 3-Methanesulfonyl-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrobenzo[c]thiophene-1-carboxylic acid 2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl ester; for treatment of metabolic disorders such as IGT (impaired glucose tolerance), Type 1 diabetes, Type 2 diabetes and obesity
1 ... 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 ... 523